Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Guangdong Hybribio Biotech (300639)
- 6.06
- -0.07-1.14%
Market Closed Apr 30 15:00 CST
3.92BMarket Cap-36.73P/E (TTM)
6.15High6.02Low132.94KlotVolume6.08Open6.13Prev Close80.74MTurnover2.09%Turnover RatioLossP/E (Static)646.50MShares10.0752wk High1.03P/B3.85BFloat Cap5.1052wk Low7.36Limit Up635.16MShs Float21.22Historical High4.90Limit Down2.12%Range %2.56Historical Low--Dividend TTM6.07Avg Price76.54KlotAsk--Div Yield TTM100Lot Size54.25KlotBid
Guangdong Hybribio Biotech (300639) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.14%125.83M | -17.89%669.64M | -20.38%485.87M | -22.96%314.99M | -26.78%134.06M | -26.16%815.53M | -28.26%610.24M | -32.60%408.88M | -39.39%183.1M | -80.27%1.1B |
| Operating revenue | -6.14%125.83M | -17.89%669.64M | -20.38%485.87M | -22.96%314.99M | -26.78%134.06M | -26.16%815.53M | -28.26%610.24M | -32.60%408.88M | -39.39%183.1M | -80.27%1.1B |
| Other operating revenue | ---- | 20.47%10.61M | ---- | -38.35%4.54M | ---- | -70.39%8.81M | ---- | -48.28%7.36M | ---- | -62.03%29.75M |
| Total operating cost | -11.13%151.54M | -23.03%774.74M | -15.07%576.38M | -21.29%375.4M | -25.42%170.51M | -8.33%1.01B | -13.05%678.69M | -8.26%476.91M | -15.14%228.64M | -61.18%1.1B |
| Operating cost | 2.78%70.9M | -14.42%365.19M | -9.60%254.79M | -11.90%167M | -24.19%68.98M | -0.86%426.72M | -13.59%281.85M | -10.36%189.55M | -21.46%90.99M | -74.90%430.42M |
| Operating tax surcharges | 47.52%2.63M | 4.70%11.75M | -9.30%6.89M | 9.99%4.24M | -0.82%1.78M | 8.68%11.22M | 13.70%7.6M | -0.20%3.85M | -11.93%1.8M | -52.02%10.33M |
| Operating expense | 3.38%35.75M | -36.01%166.88M | -19.28%138.03M | -21.44%90.74M | -35.69%34.59M | -6.56%260.8M | 8.06%171M | 13.16%115.5M | -26.62%53.78M | -39.35%279.12M |
| Administration expense | -0.28%50.6M | -6.65%206.5M | -8.60%153.05M | -15.00%101.18M | -7.91%50.75M | -12.69%221.2M | -8.63%167.46M | -4.03%119.04M | -5.93%55.11M | -34.61%253.36M |
| Financial expense | -822.39%-21.66M | -3,960.09%-37.97M | -74.54%-24.63M | -796.77%-21.82M | -188.08%-2.35M | 108.54%983.59K | -469.25%-14.11M | -56.93%3.13M | 114.74%2.67M | -309.39%-11.51M |
| -Interest expense (Financial expense) | 53.60%814.69K | 101.80%3.18M | 107.82%2.84M | 20.06%1.06M | 14.43%530.42K | -68.10%1.58M | -64.43%1.37M | -64.20%882.73K | -91.83%463.53K | -39.57%4.94M |
| -Interest Income (Financial expense) | 42.80%-3.51M | 17.25%-18.41M | 21.55%-14.08M | -13.74%-10.29M | -137.44%-6.13M | 33.59%-22.25M | -13.99%-17.95M | 23.03%-9.05M | -59.46%-2.58M | -121.99%-33.5M |
| Research and development | -20.57%13.32M | -27.15%62.39M | -25.66%48.25M | -25.71%34.05M | -31.00%16.76M | -37.18%85.64M | -36.59%64.9M | -35.58%45.84M | -35.63%24.3M | -44.87%136.32M |
| Credit Impairment Loss | 536.96%21.29M | 94.25%-34.93M | 79.24%-79.33M | 22.09%-57.56M | -149.06%-4.87M | -6,013.57%-608.01M | -7,476.32%-382.09M | -946.06%-73.89M | -38.60%9.93M | 104.10%10.28M |
| Asset Impairment Loss | 85.95%-52.66K | 27.58%-27.33M | 50.32%-10.44M | -1,257.93%-10.89M | -561.94%-374.94K | -278.14%-37.75M | -192.40%-21.01M | -104.91%-802.26K | -97.28%81.17K | 97.22%-9.98M |
| Other net revenue | 568.29%22.26M | 91.86%-51.31M | 79.32%-80.32M | 3.31%-61.27M | -134.06%-4.75M | -1,843.38%-630.68M | -772.82%-388.38M | -265.71%-63.37M | -50.09%13.96M | 106.29%36.18M |
| Fair value change income | 153.39%3.43K | 22.79%4.97M | 625,742.86%3.21M | 59,491.58%4.44M | 82.58%-6.42K | 220,818.49%4.05M | 94.12%-513.72 | 238.10%7.45K | -1,204.98%-36.87K | -104.30%-1.83K |
| Invest income | 95.19%-23.56K | -121.83%-1.13M | -88.80%986.8K | -96.66%243.38K | -135.25%-489.98K | -63.04%5.15M | -18.20%8.81M | -36.95%7.3M | 2,032.87%1.39M | -34.56%13.94M |
| -Including: Investment income associates | 69.10%-95.6K | -2,196.31%-2.78M | -45.74%-292.39K | -277.54%-593.74K | -3.14%-309.38K | 85.65%-121K | 70.01%-200.62K | 77.78%-157.26K | 47.99%-299.96K | 24.72%-843.13K |
| Asset deal income | -1,229.94%-315.66K | 274.49%434.23K | -64.99%589.43K | -54.77%358.18K | -107.48%-23.73K | -103.52%-248.85K | -75.14%1.68M | -88.36%791.92K | 1,858.31%317.28K | 62.79%7.06M |
| Other revenue | 34.19%1.36M | 9.07%6.68M | 10.16%4.66M | -33.51%2.14M | -55.42%1.01M | -58.85%6.12M | -65.56%4.23M | -69.58%3.22M | -74.36%2.27M | 63.23%14.87M |
| Operating profit | 91.63%-3.45M | 80.97%-156.41M | 62.60%-170.83M | 7.40%-121.68M | -30.47%-41.2M | -2,028.93%-821.72M | -457.49%-456.83M | -205.09%-131.4M | -152.07%-31.58M | -98.06%42.6M |
| Add:Non operating Income | -69.01%19.35K | 198.71%2.19M | -44.81%563.53K | -89.14%90.3K | -90.73%62.45K | 24.55%731.93K | 106.04%1.02M | 383.36%831.18K | 898.49%674.05K | 122.38%587.65K |
| Less:Non operating expense | -93.47%237.48K | 26.06%15.1M | 52.25%7.09M | 138.86%5.57M | 40.36%3.64M | 88.03%11.98M | -34.00%4.66M | -42.82%2.33M | 49.08%2.59M | -90.28%6.37M |
| Total profit | 91.81%-3.67M | 79.67%-169.32M | 61.48%-177.36M | 4.32%-127.16M | -33.68%-44.78M | -2,362.51%-832.97M | -479.82%-460.46M | -209.73%-132.9M | -156.80%-33.5M | -98.27%36.82M |
| Less:Income tax cost | 771.09%2.76M | -88.96%12.96M | 120.12%12.02M | 380.46%9.96M | 92.79%-411.25K | 470.31%117.38M | -1,411.28%-59.74M | -111.18%-3.55M | -145.01%-5.7M | -109.72%-31.7M |
| Net profit | 85.51%-6.43M | 80.82%-182.28M | 52.74%-189.38M | -6.00%-137.12M | -59.62%-44.36M | -1,487.08%-950.35M | -443.45%-400.72M | -244.76%-129.35M | -160.02%-27.79M | -96.20%68.51M |
| Net profit from continuing operation | 85.51%-6.43M | 80.82%-182.28M | 52.74%-189.38M | -6.00%-137.12M | -59.62%-44.36M | -1,487.08%-950.35M | -443.45%-400.72M | -244.76%-129.35M | -160.02%-27.79M | -96.20%68.51M |
| Less:Minority Profit | 78.71%-3.63M | 82.62%-51.34M | 55.55%-61.7M | 9.34%-47.53M | -26.94%-17.06M | -310.61%-295.47M | -150.41%-138.8M | -56.56%-52.42M | 29.44%-13.44M | -194.92%-71.96M |
| Net profit of parent company owners | 89.76%-2.8M | 80.01%-130.94M | 51.25%-127.68M | -16.46%-89.59M | -90.21%-27.3M | -566.20%-654.88M | -252.19%-261.92M | -162.62%-76.93M | -121.96%-14.35M | -91.86%140.47M |
| Earning per share | ||||||||||
| Basic earning per share | 89.81%-0.0043 | 79.41%-0.21 | 50.93%-0.1996 | -17.15%-0.14 | -111.00%-0.0422 | -508.00%-1.02 | -253.92%-0.4068 | -162.89%-0.1195 | -113.33%-0.02 | -90.46%0.25 |
| Diluted earning per share | 89.81%-0.0043 | 79.41%-0.21 | 50.93%-0.1996 | -17.15%-0.14 | -111.00%-0.0422 | -508.00%-1.02 | -253.92%-0.4068 | -162.89%-0.1195 | -113.33%-0.02 | -90.46%0.25 |
| Other composite income | 2,336.51%74.74M | -1,554.68%-66.75M | -465.64%-37.14M | -319.85%-21.37M | -498.49%-3.34M | -73.66%4.59M | -132.85%-6.57M | -60.87%9.72M | 103.10%838.66K | -79.04%17.42M |
| Other composite income of parent company owners | 2,336.51%74.74M | -1,554.68%-66.75M | -465.64%-37.14M | -319.85%-21.37M | -498.49%-3.34M | -73.66%4.59M | -132.85%-6.57M | -60.87%9.72M | 103.10%838.66K | -79.04%17.42M |
| Total composite income | 243.20%68.31M | 73.67%-249.03M | 44.38%-226.52M | -32.47%-158.48M | -76.98%-47.71M | -1,200.58%-945.76M | -398.03%-407.28M | -204.76%-119.63M | -240.04%-26.96M | -95.44%85.93M |
| Total composite income of parent company owners | 334.77%71.95M | 69.60%-197.69M | 38.61%-164.82M | -65.09%-110.96M | -126.74%-30.65M | -511.86%-650.29M | -239.77%-268.49M | -145.51%-67.21M | -135.29%-13.52M | -91.27%157.89M |
| Total composite income of minority owners | 78.71%-3.63M | 82.62%-51.34M | 55.55%-61.7M | 9.34%-47.53M | -26.94%-17.06M | -310.61%-295.47M | -150.41%-138.8M | -56.56%-52.42M | 29.44%-13.44M | -194.92%-71.96M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm